These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


303 related items for PubMed ID: 6375316

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
    Kohri K, Kurita T, Sakaguti H, Kadowaki T, Iguti M, Kanda H, Nagi N, Kataoka K, Kawamura M, Mitsubayashi S.
    Hinyokika Kiyo; 1989 Apr; 35(4):711-6. PubMed ID: 2660527
    [Abstract] [Full Text] [Related]

  • 23. [Clinical studies on cefsulodin in the pediatric field].
    Aoyama R, Kakizaki Y, Ohnishi A, Izumi Y, Kuronuma T, Nomura Y.
    Jpn J Antibiot; 1982 Nov; 35(11):2629-32. PubMed ID: 7169662
    [Abstract] [Full Text] [Related]

  • 24. [Clinical studies of efficacy of imipenem/cilastatin sodium against urinary tract infections with ureterocutaneostomy].
    Yogi S, Yoshikawa H, Ikeuchi T, Kai Y.
    Hinyokika Kiyo; 1992 Mar; 38(3):373-7. PubMed ID: 1523997
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical study of cefsulodin on Pseudomonas aeruginosa infections in otorhinolaryngology].
    Makishima K, Nakashima T, Toriya Y, Murata Y, Watanabe H, Kannae S.
    Jpn J Antibiot; 1982 Dec; 35(12):2835-8. PubMed ID: 7182538
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y, Funaki H, Takagane H, Tanji S, Abe T, Aoki H, Kubo T, Ohori T.
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical evaluation of aztreonam for complicated urinary tract infection].
    Moriguchi R, Yamagoshi T, Nagakubo I, Aoki S.
    Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Reevaluation of clinical efficacy of piperacillin against complicated urinary tract infections].
    Ueno M, Ikeuchi T, Kai Y.
    Hinyokika Kiyo; 1988 Sep; 34(9):1675-8. PubMed ID: 3213800
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A, Tice AD, McCarty J, Sikes DH, Nolen T, Gallis HA, Whalen EP, Tosiello RL, Heyd A, Kowalsky SF.
    Arch Intern Med; 1995 Mar 13; 155(5):485-94. PubMed ID: 7864704
    [Abstract] [Full Text] [Related]

  • 36. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A, Klimberg I, Briefer C, Munera C, Kowalsky SF, Echols RM.
    J Antimicrob Chemother; 1999 Mar 13; 43 Suppl A():67-75. PubMed ID: 10225575
    [Abstract] [Full Text] [Related]

  • 37. [Treatment of complicated urinary tract infections by ofloxacin].
    Yoshida K, Takahashi T, Nakame Y, Saitoh H, Negishi T, Horiuchi S, Kaneoya F, Tari K, Satake I, Kojima S.
    Hinyokika Kiyo; 1988 Feb 13; 34(2):394-401. PubMed ID: 3163876
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical evaluation of cefsulodin in Pseudomonas infections in children].
    Meguro H, Ozawa S, Koike Y, Hiraiwa M, Hashimoto G, Hashira S, Fujii R, Takahashi A.
    Jpn J Antibiot; 1982 Nov 13; 35(11):2639-51. PubMed ID: 7169664
    [Abstract] [Full Text] [Related]

  • 40. [Clinical studies on combination therapy of cephem antibiotics in chronic complicated urinary tract polymicrobial infections due to Pseudomonas aeruginosa and other bacteria].
    Fujimura N, Yuasa K, Uema K, Kurokawa K.
    Jpn J Antibiot; 1984 Sep 13; 37(9):1669-78. PubMed ID: 6096584
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.